Attached files

file filename
EX-10.1 - EXHIBIT - EXACTECH INCform8-kceoamendmentxexhibi.htm


    
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

Date of Report (Date of earliest event reported): December 31, 2013


EXACTECH, INC.

(Exact Name of Registrant as Specified in Its Charter)

Florida
0-28240
59-2603930
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)

2320 NW 66th Court
Gainesville, Florida 32653
(Address of Principal Executive Office)

Registrant’s telephone number, including area code (352) 377-1140


(Former Name or Former Address, if Changed Since Last Report)

__________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR     240.14d-2(b))

[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR     240.13e-4(c))








Item 1.01 Entry into a Material Definitive Agreement.

The information contained in Item 5.02 is incorporated by reference in this Item 1.01.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 31, 2013, Exactech, Inc., a Florida corporation (the “Company”), and Dr. William Petty, the Company’s Chief Executive Officer and Chairman of the Board of Directors, executed an amendment (the "Amendment") to that certain employment agreement, dated as of January 1, 2012, between Dr. Petty and the Company (the “Original Agreement” and, as amended by the Amendment, the “Agreement”). The Amendment extends the current term under the Original Agreement from December 31, 2013 to February 28, 2014 with the Subsequent Term (as defined in the Agreement) to begin on March 1, 2014. The Company and Dr. Petty agreed to extend the original term under the Agreement pending negotiation of a new employment agreement. Except as described in this Item 5.02, all other terms of the Agreement remain unchanged. The foregoing description of the Amendment is only a summary and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.

Item 9.01.    Financial Statements and Exhibits.

(d) Exhibits.
Exhibit
Number                Description
10.1        Amendment to employment agreement between Exactech, Inc. and R. William Petty, M.D.






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

EXACTECH, INC.
      
Date:
January 3, 2014
 
By:
/s/ Joel C. Phillips
 
 
 
 
Joel C. Phillips
 
 
 
 
Chief Financial Officer








EXHIBIT INDEX
Exhibit Number
Description
10.1
Amendment to employment agreement between Exactech, Inc. and R. William Petty, M.D.